Basic info
Industry
biotechnology research
Sectors
Biotechnology
CF
Novel therapies for chronic respiratory diseases
Therapeutics
Pharmaceutical
Asthma
COPD
Date founded
2005
Funding rounds raised
Total raised
$200M
from 18 investors over 18 rounds
V
Verona Pharma raised $150M on October 17, 2022
Investors: Oxford Finance LLC
V
Verona Pharma raised $200M on July 17, 2020
Investors: Perceptive Advisors, Samsara BioCapital, PBM Capital Group, RA Capital Management, L.P., Soleus Capital Management, L.P., Novo Holdings, OrbiMed Advisors, Vivo Capital and Polar Capital Partners
V
Verona Pharma raised $65M on June 20, 2016
Investors: Aisling Capital, OrbiMed Advisors, Andera Partners, Arthurian Life Sciences, Vivo Capital, Novo Holdings and Abingworth
V
Verona Pharma raised $12M on February 6, 2012
Investors: HENDERSON GLOBAL INVESTORS LIMITED